Problem statement: Answer the multiple-choice question.
Query: Which drug has a 4.285\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: Cc1nc2cc3nc(C(F)(F)F)[nH]c3cc2[nH]1
b: COc1ccc(OC)c(NC(=O)CSc2nc3cccnc3n2C)c1
c: CCCc1cc(NC(=O)CCl)n(-c2ccccc2)n1
d: COC(=O)c1cn(CC(=O)Nc2ccc(F)cc2)c2ccccc12
Answer: b. COc1ccc(OC)c(NC(=O)CSc2nc3cccnc3n2C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(OC)c(NC(=O)CSc2nc3cccnc3n2C)c1
COc1ccc(OC)c(NC(=O)CSc2nc3cccnc3n2C)c1
N-(2,5-dimethoxyphenyl)-2-(3-methylimidazo[4,5-b]pyridin-2-yl)sulfanylacetamide